|
|
November 2008 Research Alert
New Research this month offers detail-rich studies that cut across major functions and operations that include sales, manufacturing, product launch and competitive intelligence. With insights into fixed-dose combination manufacturing, the evolving role of the district sales manager, and navigating the gray zones of competitive intelligence, these studies offer a wealth of wide-ranging best practices from leading companies. The four new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies in the pharmaceutical sector have made their operations more effective across these different areas. Opportunities to participate in current research are also listed below.
If you are not a member of the Best Practice Database but would still like to receive a monthly Research Alert via email, just sign-up here.
Newly Added Research
Note that study report and document purchases can be credited toward a membership in the Best Practice Database (http://www.bestpracticedatabase.com/), where our latest research as well as hundreds of additional concise research documents and presentations can be accessed on-demand.
Best Practice Database Documents
- Product Commercialization Excellence: Preparation and Management of Fixed-Dose Combination (FDC) Drug Products (ID 5013)
- Evolution of the District Sales Manager Role (ID 5016)
Benchmarking Reports
- Pharmaceutical Product Launch Evaluation Excellence: Processes and Measures to Evaluate Launch Success (PSM-230)
- Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone (SM-179)
Current Surveys
The following is a list of study topics with respective participation closing dates.
- Update: Roles, Resourcing and Management of Field-Based Medical Specialists (December 22)
- Optimizing Sales Training Resources for Maximum Productivity in First-Year Reps (December 22)
|
|